Larvol Delta - Cognition-Therapeutics-Completes-EndofPhase-2-Meeting-with-FDA-for-Zervimesine-CT1812-in-Alzheimers-Disease

Elayta (zervimesine) - Cognition Therap

https://www.globenewswire.com/news-release/2025/07/10/3113149/0/en/Cognition-Therapeutics-Completes-End-of-Phase-2-Meeting-with-FDA-for-Zervimesine-CT1812-in-Alzheimer-s-Disease.html

Jul 10, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next